1-866-647-3279
dicentra Special Alert: Proposal to amend the Food and Drug Regulations – Project 1663 – Schedule F Amendment
February 23, 2012 By
FOR IMMEDIATE RELEASEProposal to amend the Food and Drug Regulations -(addition of pancrelipase, pancreatin and pancreatic enzymes) – Project 1663 – Schedule F Amendment In November 2011, the NHPD (rather […] Read More >>
Update on Enzymes and Probiotics in Canada
January 10, 2012 By
by Manushvi Chadha, BPharm, RA Cert Regulatory Affairs Associate, dicentra The past year had the NHPD re-evaluate their strategy for enzyme and probiotic-containing products, which had been on hold for […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions

      *Please note: dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in Canada, to the exclusion of all other countries.